Studies have shown that ginsenoside rh2 (Table 1) upregulates the secretion levels of TNF-α and IL-6 in the serum of colon cancer mice, relieves tumor-related immunosuppression, and prolongs the survival of colon cancer mice [73]. Here, IL6 is linked to malignant colon neoplasm.